TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Double Bond Pharmaceutical AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,418
|
1,342
|
1,076 |
Financial expenses |
108
|
2,731
|
1,193 |
Earnings before taxes |
-10,487
|
-13,910
|
-17,786 |
EBITDA |
-10,187
|
-10,986
|
-16,423 |
Total assets |
4,486
|
4,811
|
11,588 |
Current assets |
4,034
|
4,183
|
9,485 |
Current liabilities |
2,456
|
3,194
|
3,753 |
Equity capital |
2,030
|
1,617
|
7,835 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
10
![]() |
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.3%
|
33.6%
|
67.6% |
Turnover per employee |
142
|
134
|
108 |
Profit as a percentage of turnover |
-739.6%
|
-1036.5%
|
-1653.0% |
Return on assets (ROA) |
-231.4%
|
-232.4%
|
-143.2% |
Current ratio |
164.3%
|
131.0%
|
252.7% |
Return on equity (ROE) |
-516.6%
|
-860.2%
|
-227.0% |
Change turnover |
76
|
266
|
639 |
Change turnover % |
6%
|
25%
|
146% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.